These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 794959)

  • 1. Lymphocyte-macrophage interactions in BCG-treated mice.
    Florentin I; Bruley-Rosset M; Davigny M
    Recent Results Cancer Res; 1976; (56):49-57. PubMed ID: 794959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for two distinct populations of suppressor cells in the spleens of Mycobacterium bovis BCG-Sensitized mice.
    Turcotte R
    Infect Immun; 1981 Nov; 34(2):315-22. PubMed ID: 6458564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mode of action of BCG.
    Mitchell MS; Kirkpatrick D; Mokyr MB; Gery I
    Nat New Biol; 1973 Jun; 243(128):216-8. PubMed ID: 4197570
    [No Abstract]   [Full Text] [Related]  

  • 4. Active suppression of in vitro reactivity of spleen cells after BCG treatment.
    Orbach-Arbouys S; Poupon MF
    Immunology; 1978 Mar; 34(3):431-7. PubMed ID: 305890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
    Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
    Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells.
    Meltzer MS; Oppenheim JJ
    J Immunol; 1977 Jan; 118(1):77-82. PubMed ID: 137265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
    Klimpel GR; Okada M; Henney CS
    J Immunol; 1979 Jul; 123(1):350-7. PubMed ID: 156233
    [No Abstract]   [Full Text] [Related]  

  • 8. Infection with Bacillus Calmette-Guérin activates murine thymus-independent (B) lymphocytes.
    Sultzer BM
    J Immunol; 1978 Jan; 120(1):254-61. PubMed ID: 342604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of CD8 T cells with specificity for mycobacterial heat shock protein 60 in Mycobacterium bovis bacillus Calmette-Guérin-vaccinated mice.
    Zügel U; Kaufmann SH
    Infect Immun; 1997 Sep; 65(9):3947-50. PubMed ID: 9284177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I; Radzioch D; Skamene E
    Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of BCG on spleen and lymph node cells: lymphocyte proliferation and immunoglobulin synthesis.
    Turcotte R; Lafleur L; Labrèche M
    Infect Immun; 1978 Sep; 21(3):696-704. PubMed ID: 361574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of Ehrlich ascites carcinoma in BCG-sensitized mice.
    Turcotte R
    Rev Can Biol; 1977 Sep; 36(3):253-63. PubMed ID: 928853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG.
    Castés M; Lynch NR; Lespinats G; Orbach-Arbouys S
    Br J Cancer; 1981 Dec; 44(6):828-37. PubMed ID: 6459797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse. I. Generation of suppressor macrophages in spleen cells of BCG-vaccinated mice.
    Yagi H; Matsumoto M; Suzuki S; Misaki R; Suzuki R; Makino S; Harada M
    Cell Immunol; 1991 Nov; 138(1):130-41. PubMed ID: 1833072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migration of natural suppressor cells from bone marrow to peritoneal cavity by live BCG.
    Kato K; Yamamoto K; Kimura T
    J Immunol; 1985 Dec; 135(6):3661-8. PubMed ID: 2933452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the migration of mouse lymphoid cells by BCG: a factor stimulating T-cell migration.
    Castes M; Borderie N; Orbach-Arbouys S
    Cell Immunol; 1978 Sep; 40(1):37-45. PubMed ID: 359172
    [No Abstract]   [Full Text] [Related]  

  • 19. Negative and positive immunobiological responses in mice pretreated with Bacillus Calmette-Guérin cell wall.
    Mizushima Y; Wepsic HT; Yamamura Y; DeSilva MA; Janns G; Larson CH
    Cancer Res; 1984 Jan; 44(1):20-4. PubMed ID: 6228292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacille Calmette-Guérin infection in the mouse. Regulation of macrophage plasminogen activator by T lymphocytes and specific antigen.
    Gordon S; Cohn ZA
    J Exp Med; 1978 Apr; 147(4):1175-88. PubMed ID: 349108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.